These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 15113313)

  • 1. Human fascioliasis.
    Saba R; Korkmaz M; Inan D; Mamikoğlu L; Turhan O; Günseren F; Cevikol C; Kabaalioğlu A
    Clin Microbiol Infect; 2004 May; 10(5):385-7. PubMed ID: 15113313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indirect evidence of ectopic pancreatic fascioliasis in a human.
    Lee OJ; Kim TH
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1631-3. PubMed ID: 16928233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy and tolerance of praziquantel (Biltricide) in the treatment of distomatosis caused by Fasciola hepatica].
    Moreau JA; Fernandez J; Recco P; Seguela JP; Frexinos J
    Gastroenterol Clin Biol; 1995 May; 19(5):514-9. PubMed ID: 7590004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pruritus and intermittent jaundice as clinical clues for Fasciola hepatica infestation.
    Umac H; Erkek AB; Ayaşlioğlu E; Erkek E; Ozluk U; Onen N
    Liver Int; 2006 Aug; 26(6):752-3. PubMed ID: 16842334
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pseudotumor form of hepatic distomatosis: successful treatment with praziquantel].
    Queneau PE; Koch S; Bresson-Hadni S; Bartholomot B; Arbez-Gindre F; Heyd B; Miguet JP
    Gastroenterol Clin Biol; 1997; 21(6-7):511-3. PubMed ID: 9295980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection with Fasciola hepatica.
    Aksoy DY; Kerimoglu U; Oto A; Erguven S; Arslan S; Unal S; Batman F; Bayraktar Y
    Clin Microbiol Infect; 2005 Nov; 11(11):859-61. PubMed ID: 16216098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imported Fasciola hepatica infection in the United States and treatment with triclabendazole.
    Graham CS; Brodie SB; Weller PF
    Clin Infect Dis; 2001 Jul; 33(1):1-5. PubMed ID: 11389487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 12-2002. A 50-year-old man with eosinophilia and fluctuating hepatic lesions.
    MacLean JD; Graeme-Cook FM
    N Engl J Med; 2002 Apr; 346(16):1232-9. PubMed ID: 11961153
    [No Abstract]   [Full Text] [Related]  

  • 9. Conservative management of biliary obstruction due to Fasciola hepatica.
    Mannstadt M; Sing A; Leitritz L; Brenner-Maucher K; Bogner J
    Clin Infect Dis; 2000 Nov; 31(5):1301-3. PubMed ID: 11073771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fasciola hepatica infestation. Biopathology and new diagnostic and therapeutic aspects].
    de Górgolas M; Torres R; Verdejo C; Garay J; Robledo A; Ponte MC; Fernández Guerrero ML
    Enferm Infecc Microbiol Clin; 1992 Nov; 10(9):514-9. PubMed ID: 1489790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fascioliasis imported to Norway.
    Jensenius M; Flaegstad T; Stenstad T; Gjølberg T; Vlatkovic L; Schjøth-Iversen L; Berild D; Bordmann G; Myrvang B
    Scand J Infect Dis; 2005; 37(6-7):534-7. PubMed ID: 16012024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A human case of invasive fascioliasis associated with liver abscess.
    Kim JB; Kim DJ; Huh S; Cho SY
    Korean J Parasitol; 1995 Dec; 33(4):395-8. PubMed ID: 8591020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Distomatosis: diagnosis and treatment].
    Delasalle P; Beytout J; Cambon M; Bommelaer G
    Rev Prat; 1990 Jan; 40(3):230-6. PubMed ID: 2305189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Infection with fasciola hepatica causing elevated liver-enzyme results and eosinophilia - serologic and endoscopic diagnosis and therapy].
    Christmann M; Henrich R; Mayer G; Ell C
    Z Gastroenterol; 2002 Sep; 40(9):801-6. PubMed ID: 12215949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eight cases of fascioliasis: clinical and microbiological features.
    Dauchy FA; Vincendeau P; Lifermann F
    Med Mal Infect; 2006 Jan; 36(1):42-6. PubMed ID: 16309872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hiding in the Water.
    Micic D; Oto A; Charlton MR; Benoit JL; Siegler M
    N Engl J Med; 2020 May; 382(19):1844-1849. PubMed ID: 32374966
    [No Abstract]   [Full Text] [Related]  

  • 17. Activity of artemether and OZ78 against triclabendazole-resistant Fasciola hepatica.
    Keiser J; Utzinger J; Vennerstrom JL; Dong Y; Brennan G; Fairweather I
    Trans R Soc Trop Med Hyg; 2007 Dec; 101(12):1219-22. PubMed ID: 17905370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human fascioliasis: a case of hyperinfection and an update for clinicians.
    Arauco R; Zetola NM; Calderon F; Seas C
    Foodborne Pathog Dis; 2007; 4(3):305-12. PubMed ID: 17883314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compartive studies on the effect of bithionol, praziqantel and triclabendazole in rabbit's fascioliasis. 1. Parasitological studies.
    el-Sayad MH
    J Egypt Soc Parasitol; 1997 Apr; 27(1):131-42. PubMed ID: 9097534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of antibodies and circulating excretory-secretory antigens for assessing cure in patients with fascioliasis.
    Espino AM; Millán JC; Finlay CM
    Trans R Soc Trop Med Hyg; 1992; 86(6):649. PubMed ID: 1287933
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.